[ Back to EurekAlert! ] Public release date: 16-Dec-2004
[ | E-mail Share Share ]

Contact: Krista Johnston
kristaj@cmmt.ubc.ca
604-875-3881
University of British Columbia

Scientists discover enzyme crucial to the transportation of proteins within cells

VANCOUVER, B.C. - December 16, 2004: Scientists at the University of British Columbia have discovered an enzyme in mammals crucial to the transportation of proteins within cells. Published today in Neuron, this discovery opens new avenues of understanding of the mechanisms underlying neuronal function and new therapeutic approaches for neurodegenerative diseases such as Alzheimers and Huntington Disease.

The enzyme, HIP14, is a palmitoyl transferase that adds signaling molecules to proteins resulting in their transportation to specific cellular locations where they perform essential functions. This process known as palmitoylation is extremely important for the normal functioning of the nervous system where proteins are transported rapidly within nerve cells known as neurons.

Until now, scientists did not know how mammalian proteins become palmitoylated. During their study of Huntington Disease, Dr. Michael Hayden's team at the Centre for Molecular Medicine and Therapeutics had previously identified a protein called HIP14 and recognized that it might play a role in palmitoylation. To further understand this mechanism, the Hayden team formed a partnership with Dr. Alaa El-Husseini and his team at the Brain Research Centre who are experts in the field of protein palmitoylation. Through this unique collaboration between experts in complementary fields, they discovered that HIP14 is indeed a mammalian palmitoyl transferase.

The teams also discovered that in the absence of the HIP14 enzyme, proteins were not transported to locations in the cell where they are needed. This change in protein trafficking is thought to result in severe neuronal dysfunction and may be a mechanism underlying diseases such as Alzheimers and Huntington Disease.

This research was funded by the Michael Smith Foundation for Health Research, the Canadian Institute of Health Research and the High Q Foundation.

###

Journal Article: Neuron, Vol. 44, 977- 986, December 16, 2004

The Centre for Molecular Medicine and Therapeutics (CMMT) is a joint alliance between the BC Research Institute for Children's and Women’s Health, the University of British Columbia, Children's and Women's Health Centre of British Columbia (C&W's), Merck Frosst Canada Inc. and the Government of British Columbia. The CMMT is dedicated to understanding the molecular function and structure of genes as the key to improved diagnosis, treatment and prevention of health problems in children and adults.

The Brain Research Centre is a unique partnership between Vancouver Coastal Health and the Faculty of Medicine at the University of British Columbia. The hospital has combined forces with broad, multi disciplinary research expertise at the University of British Columbia to advance our knowledge of the brain and to explore new discoveries and technologies which have the potential to reduce the suffering and cost associated with disease and injuries of the brain.


[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.